FORBES-TATE

Lobbying for IONIS PHARMACEUTICAL, INC. · Biopharmaceutical company developing RNA therapies.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Medicare/Medicaid

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.